Insight Molecular Diagnostics Inc.·4

Jul 6, 8:35 PM ET

Arno Andrew 4

Research Summary

AI-generated summary

Updated

Insight Molecular Diagnostics (IMDX) Director Arno Andrew Withholds 12,100 Shares for Taxes

What Happened
Arno Andrew, a director of Insight Molecular Diagnostics (IMDX), had 12,100 shares withheld by the company on July 1, 2026 to satisfy tax withholding obligations tied to the vesting of 55,000 restricted stock units (RSUs). The withholding was recorded at $5.69 per share for a total tax-withholding value of $68,849. The reporting person did not sell any shares; after withholding he effectively received 42,900 shares from the RSU vesting.

Key Details

  • Transaction date: 2026-07-01; per-share value used for withholding: $5.69; total withheld value: $68,849. (Transaction code F = tax withholding.)
  • RSU vesting: 55,000 shares vested; 12,100 were withheld for taxes, leaving 42,900 delivered to the reporting person.
  • Shares held via entities: Footnotes state some common stock is held by JBA Investments LLC and MJA Investments LLC; Andrew is the Manager of both and has voting/disposal rights over those holdings (F2, F3).
  • Filing: Form 4 was filed 2026-07-06 for a 2026-07-01 transaction — this appears outside the standard two-business-day Form 4 window and thus may be late.

Context
Code F transactions are routine tax-withholding events tied to awards vesting and do not represent an open-market sale or purchase; the reporting person did not sell shares. The withholding reduces the number of shares delivered from the RSU grant but is not a bearish signal about company prospects.